Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07101289 · ClinicalTrials.gov registry record · NA
Eat Well Heart Failure
A NA study of Congestive Heart Failure Chronic, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 900
- Enrollment target
- 1
- Study location
NCT07101289: Recruiting NA study of Congestive Heart Failure Chronic, sponsored by Duke University.
NCT07101289 is a NA study of Congestive Heart Failure Chronic that is actively recruiting participants, run by Duke University. The registered enrollment target is 900 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07101289, a NA study of Congestive Heart Failure Chronic, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 900 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this parallel pragmatic randomized controlled trial (RCT) is to evaluate the impact of Eat Well (an evidence-based 'Food is Medicine' produce prescription program) with varying levels of behavioral support on health outcomes and care utilization patterns of Duke Health patients diagnosed with congestive heart failure (CHF). Objectives of this three arm trial include testing the effectiveness of Eat Well alone with minimal behavioral support and Eat Well with intensified behavioral support based on an evidence based approach to improve CHF patients' health outcomes, estimating health care cost savings between the intervention and control arms, and identifying barriers, facilitators, and potential strategies to enhance Eat Well effectiveness and implementation.
Primary Outcome
The primary outcome of interest will be a composite endpoint of: ED visits, hospitalizations, and all-cause mortality at 12 months.
Conditions Studied
Interventions
- BEHAVIORAL Personal health planning and nutritional coaching
- OTHER Prescription Produce
Study Locations (1)
North Carolina
- Duke Health - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2025-10-22 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT07101289 shows while recruiting
NCT07101289 is an interventional study that assigns participants to a tested intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (36% lower).
The record links to 1 condition, with Congestive Heart Failure Chronic appearing as the primary indexed condition, and to 2 interventions - of which Personal health planning and nutritional coaching is the first listed.
NCT07101289 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT07101289 about?
NCT07101289 is a clinical study titled "Eat Well Heart Failure". The purpose of this parallel pragmatic randomized controlled trial (RCT) is to evaluate the impact of Eat Well (an evidence-based 'Food is Medicine' produce prescription program) with varying levels of behavioral support on health outcomes and care utilization patterns of Duke Health patients diagno...
What is the current status of trial NCT07101289?
This trial is currently recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2025-10-22. Estimated completion is 2027-12.
What conditions does trial NCT07101289 study?
This clinical trial studies the following conditions: Congestive Heart Failure Chronic.
What interventions are being tested in trial NCT07101289?
The interventions under investigation include: Personal health planning and nutritional coaching (BEHAVIORAL), Prescription Produce (OTHER).
Who is sponsoring clinical trial NCT07101289?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07101289 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congestive Heart Failure Chronic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07101289's enrollment target sits among peer trials
900 124th of 2000 higher than 1,872 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- NCT02670408 · 900 participants
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
- NCT02960022 · 900 participants · Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI